We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$228M
AUM Growth
+$28.2M
Cap. Flow
+$16.3M
Cap. Flow %
7.18%
Top 10 Hldgs %
22.49%
Holding
2,261
New
155
Increased
919
Reduced
268
Closed
73

Sector Composition

Rank Sector Weight
1 Financials 10.77%
2 Healthcare 8.96%
3 Consumer Staples 8.9%
4 Technology 8.86%
5 Industrials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWX icon
951
Southwest Gas
SWX
$6.68B
$8K ﹤0.01%
112
+37
+49% +$3.02K
TECH icon
952
Bio-Techne
TECH
$11.2B
$8K ﹤0.01%
332
TFSL icon
953
TFS Financial
TFSL
$5.07B
$8K ﹤0.01%
492
-84
-15% -$1.47K
TFX icon
954
Teleflex
TFX
$5.91B
$8K ﹤0.01%
49
+37
+308% +$6.66K
TOL icon
955
Toll Brothers
TOL
$14.1B
$8K ﹤0.01%
284
+159
+127% +$5.3K
TTWO icon
956
Take-Two Interactive
TTWO
$44.7B
$8K ﹤0.01%
155
+55
+55% +$3.07K
VIPS icon
957
Vipshop
VIPS
$7.06B
$8K ﹤0.01%
722
+602
+502% +$7.45K
WAB icon
958
Wabtec
WAB
$50.3B
$8K ﹤0.01%
155
+32
+26% +$2.64K
WSO icon
959
Watsco Inc
WSO
$15B
$8K ﹤0.01%
60
+18
+43% +$2.69K
WRK
960
DELISTED
WestRock Company
WRK
$8K ﹤0.01%
222
+100
+82% +$5.28K
AGRX
961
DELISTED
Agile Therapeutics
AGRX
$8K ﹤0.01%
+1
New +$5.03K
HZNP
962
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$8K ﹤0.01%
572
ILG
963
DELISTED
ILG, Inc Common Stock
ILG
$8K ﹤0.01%
509
-301
-37% -$5.66K
NSM
964
DELISTED
Nationstar Mortgage Holdings
NSM
$8K ﹤0.01%
515
WG
965
DELISTED
Willbros Group
WG
$8K ﹤0.01%
3,003
NLSN
966
DELISTED
Nielsen Holdings plc
NLSN
$8K ﹤0.01%
251
+167
+199% +$7.15K
ESV
967
DELISTED
Ensco Rowan plc
ESV
$8K ﹤0.01%
266
+70
+36% +$2.84K
ABG icon
968
Asbury Automotive
ABG
$4.23B
$7K ﹤0.01%
136
+84
+162% +$5.38K
ANSS
969
DELISTED
Ansys
ANSS
$7K ﹤0.01%
81
+43
+113% +$4.31K
AVT icon
970
Avnet
AVT
$7.09B
$7K ﹤0.01%
174
+95
+120% +$4.39K
BAK icon
971
Braskem
BAK
$972M
$7K ﹤0.01%
436
+31
+8% +$652
BC icon
972
Brunswick
BC
$5.23B
$7K ﹤0.01%
+122
New +$7.21K
BSRR icon
973
Sierra Bancorp
BSRR
$533M
$7K ﹤0.01%
283
CABO icon
974
Cable One
CABO
$228M
$7K ﹤0.01%
12
COTY icon
975
Coty
COTY
$2.33B
$7K ﹤0.01%
+442
New +$8.36K

Similar funds

Quadrant Capital Group's Q1 2017 Portfolio in Review

As of Q1 2017, Quadrant Capital Group held 2,261 positions worth $228M, up 14% from $199M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Quadrant Capital Group deployed $16.3M of net new capital in Q1 2017, opening 155 new positions and adding to 919 existing holdings. Its largest new stake was Meridian Bioscience Inc: 158,483 shares worth $2.19M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Procter & Gamble, an estimated $12.5M trimmed.

  • Quadrant Capital Group's largest Q1 2017 buy was Meridian Bioscience Inc: 158,483 shares worth $2.19M.
  • Quadrant Capital Group added most to Vanguard Total Stock Market ETF in Q1 2017, an estimated $3.24M increase.
  • Quadrant Capital Group's biggest Q1 2017 reduction was Procter & Gamble, cutting an estimated $12.5M.
  • Quadrant Capital Group fully exited Harman International Industries in Q1 2017, selling an estimated $104K.
  • Quadrant Capital Group's ten largest holdings make up 22% of its $228M portfolio in Q1 2017.
  • Quadrant Capital Group opened 155 new positions and closed 73 in Q1 2017.
  • Quadrant Capital Group's portfolio value rose 14% quarter-over-quarter to $228M.

Based on Quadrant Capital Group's 13F filing for Q1 2017, filed 10 Apr 2017.